In addition to staging, breast cancers have distinct prognoses and treatment strategies based on the expression of the hormone receptors estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to breast carcinoma.